Retinoblastoma is a rare form of eye cancer that primarily affects young children, typically under the age of five. It originates in the retina, the light-sensitive tissue at the back of the eye responsible for vision. This condition is caused by genetic mutations that lead to uncontrolled cell growth in the retina.
Early signs of retinoblastoma may include a white glow in the pupil, crossed or misaligned eyes, poor vision, or a noticeable redness or swelling in the eye. If left untreated, the cancer can spread to other parts of the eye and potentially to other areas of the body.
Diagnosis of retinoblastoma involves a comprehensive eye examination, imaging tests, and genetic testing to determine the extent of the disease. Treatment options depend on the size and location of the tumor, but may include chemotherapy, radiation therapy, cryotherapy, laser therapy, or surgery.
Early detection and prompt treatment are crucial for a successful outcome. With advancements in medical technology and improved understanding of the disease, the prognosis for retinoblastoma has significantly improved over the years. Regular eye exams and awareness of potential symptoms are essential in identifying retinoblastoma at an early stage.